Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Clinical experience with repository corticotropin injection in patients with multiple sclerosis experiencing mood changes with intravenous methylprednisolone: a case series.
Flupirtine in pain management: pharmacological properties and clinical use.
The impact of sexual dysfunction on health-related quality of life in people with multiple sclerosis.
Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions.
Synaptic pathology: a shared mechanism in neurological disease.
Episode 5 with Dr. Anne Cross on the year in MS research
A silver lining of neuroinflammation: Beneficial effects on myelination.
The Effects of IFN-β 1a on the Expression of Inflammasomes and Apoptosis-Associated Speck-Like Proteins in Multiple Sclerosis Patients.
Patient trial of immunization to treat Alzheimer’s disease begins at Cedars-Sinai
Development of a recombinant immunotoxin for the immunotherapy of autoreactive lymphocytes expressing MOG-specific BCRs.
Compliance to fingolimod and other disease modifying treatments in multiple sclerosis patients, a retrospective cohort study.
EBNA1 antigen-specific CD8+ T cells in cerebrospinal fluid of patients with multiple sclerosis.
Alkali metals levels in the human brain tissue: Anatomical region differences and age-related changes.
Fingolimod, a sphingosine-1 phosphate receptor modulator, increases BDNF levels and improves symptoms of a mouse model of Rett syndrome.
Peripheral Bilateral Telangiectasiae in Multiple Sclerosis Patients Treated with Interferon B1a.
A study to evaluate the effect of ultrasound treatment on nodules in multiple sclerosis patients.
Data supporting the role of Fyn in initiating myelination in the peripheral nervous system.
Zebrafish: A new vertebrate model for visualizing myelination in vivo.
Magnetic resonance imaging outcomes from a phase III trial of teriflunomide.
Dimethyl fumarate attenuates cerebral edema formation by protecting the blood-brain barrier integrity.
Assessment of structural and functıonal vısual outcomes ın relapsıng remıttıng multıple sclerosıs wıth vısual evoked potentıals and optıcal coherence tomography.
Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity.
The nature of genetic susceptibility to multiple sclerosis: constraining the possibilities.
A Cross-Sectional Study of the Impact of Spasticity on Daily Activities in Multiple Sclerosis.
More Than 15 Years of Experience with Intradetrusor OnabotulinumtoxinA Injections for Treating Refractory Neurogenic Detrusor Overactivity: Lessons to Be Learned.

Pages